Navigation Links
Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2012 Financial Results
Date:3/19/2013

ecutive Officer of Savient.  "Part of this long-term corporate strategy is to ensure that the true value of this highly effective orphan drug is reflected appropriately.  The recent 30% price increase of KRYSTEXXA represents management's commitment to execute upon this strategy and continue to build long-term value for our stakeholders."

Fourth Quarter Operational Highlights and Recent Developments:

  • Announced additional new data demonstrating KRYSTEXXA-treated refractory chronic gout patients experienced significantly improved health-related quality of life
  • Announced new data from an open-label extension (OLE) study published in the Annals of the Rheumatic Diseases reinforcing the safety and efficacy profile of KRYSTEXXA
  • Announced the elections of Robert G. Savage and Dr. David Meeker to the Company's board of directors
  • Completed study of KRYSTEXXA in dialysis patients, and anticipate data to be presented at a major scientific meeting later this year
  • Received European Commission marketing authorization in January 2013 for KRYSTEXXA® for the treatment of certain patients with chronic tophaceous gout in the EU
  • Announced a co-promotion agreement with Swedish Orphan Biovitrum AB (Sobi) for Kineret® (anakinra) in the U.S.
  • Financial Results of Operations for the Three Months Ended December 31, 2012Net revenues increased $1.2 million, or 33%, to $4.9 million for the three-month period ended December 31, 2012, from $3.7 million for the three-month period ended December 31, 2011, as a result of increasing awareness and acceptance of KRYSTEXXA among our target customer base, and to a lesser extent, the impact of our price increases.  Over the past year, we have increased the selling price of KRYSTEXXA by approximately 29% from the original list price of $2,300 per vial to $2,962 per vial.  We further increased the selling price in 2013 by
    '/>"/>

    SOURCE Savient Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related biology technology :

    1. Savient Pharmaceuticals Reports Second Quarter 2012 Financial Results
    2. New Opportunity: The Biomedical Innovations of Tomorrow - Research Report on PhotoMedex, Axiall Corp, Varian Medical Systems, Volcano Corporation and Navidea Biopharmaceuticals
    3. Keryx Biopharmaceuticals to Present at the 25th Annual ROTH Conference
    4. Regeneron Pharmaceuticals’ Industrial Operations & Product Supply Site Receives International Recognition for Operational Excellence
    5. Leica Biosystems and Synthon Biopharmaceuticals Partner to Develop a Companion Diagnostic Program for Targeted Cancer Therapies
    6. Radiopharmaceuticals Market - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 - 2018: MarketResearchReports.Biz
    7. Alexandria Real Estate Equities, Inc. Announces Long-Term Lease with Leading Global Commercial-Stage Oncology Company, Onyx Pharmaceuticals, Inc., for New Build-to-Suit Facility in South San Francisco, California
    8. AVANIR Pharmaceuticals To participate in two conferences in March
    9. Auxilium Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2012 Financial Results and Guidance for 2013
    10. Serialization in Pharmaceuticals, a Webinar Presented by Xtalks
    11. A Look Inside, Factors of Health - Research Report on Novogen Limited, Sanofi SA, ISIS Pharmaceuticals, Inc., Amgen, Inc. and Gilead Sciences, Inc.
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/10/2014)... July 10, 2014 Unraveling life’s mysteries ... The Archer Family purchased a DNA test ... but ended up with a lifetime of memories, sharing, ... the family members’ DNA genuinely brought the family closer ... search deeper into genetic history and prior to taking ...
    (Date:7/10/2014)... POINT, Ind. , July 10, 2014 ... expanded its use of capnography for respiratory ... growing group of healthcare leaders in embracing ... measures how effectively patients are breathing and ... depression occurs. By measuring the amount of ...
    (Date:7/10/2014)... 2014   Ceres, Inc . (Nasdaq: ... today financial results for the three months ended May ... Ceres reported that the company and its ... growing season in Brazil, which concluded in June, despite ... evaluation areas for part of the growing season. Yields ...
    (Date:7/10/2014)... the basis of psychiatric disorders has been extremely challenging ... risk but are insufficient to cause disease. Now investigators ... Press journal Cell Stem Cell describe a ... risks interact with other risk factors or environmental exposures ... research pinpoints a genetic variant that may predispose individuals ...
    Breaking Biology Technology:Ancestry DNA Test Reveals a Controversial and Undiscovered Family History 2Ancestry DNA Test Reveals a Controversial and Undiscovered Family History 3Ancestry DNA Test Reveals a Controversial and Undiscovered Family History 4Ancestry DNA Test Reveals a Controversial and Undiscovered Family History 5Franciscan St. Anthony Health-Crown Point Underscores Patient Safety Commitment Through Expanded Use of Capnography 2Ceres Announces Fiscal Third Quarter 2014 Financial Results 2Ceres Announces Fiscal Third Quarter 2014 Financial Results 3Ceres Announces Fiscal Third Quarter 2014 Financial Results 4Ceres Announces Fiscal Third Quarter 2014 Financial Results 5Ceres Announces Fiscal Third Quarter 2014 Financial Results 6Ceres Announces Fiscal Third Quarter 2014 Financial Results 7Ceres Announces Fiscal Third Quarter 2014 Financial Results 8Ceres Announces Fiscal Third Quarter 2014 Financial Results 9New strategy could uncover genes at the root of psychiatric illnesses 2
    ... DCTH ), a medical technology company testing its proprietary ... today that Eamonn P. Hobbs, 51, a member of the Delcath ... CEO of the Company. Mr. Hobbs succeeds Richard Taney who ... serve on the Company,s Board of Directors. , ...
    ... genetics (Nasdaq: DCGN ) and academic colleagues from ... Nature Genetics the discovery of common genetic risk ... fair and dark complexions alike. deCODE had previously discovered five ... (SNPs) linked to risk of BCC, the most common cancer ...
    ... , NEW BRUNSWICK, N.J., July 3 Johnson & Johnson (NYSE: ... of its tender offer for all outstanding shares of common stock ... midnight (Eastern time) on July 2, 2009. The offer was ... Kite Merger Sub, Inc. , , The depositary for the ...
    Cached Biology Technology:Eamonn Hobbs Appointed President & CEO of Delcath Systems, Inc. 2Eamonn Hobbs Appointed President & CEO of Delcath Systems, Inc. 3It's Not Just the Sun: deCODE Discovers Sequence Variants Affecting Susceptibility to Skin Cancer 2It's Not Just the Sun: deCODE Discovers Sequence Variants Affecting Susceptibility to Skin Cancer 3It's Not Just the Sun: deCODE Discovers Sequence Variants Affecting Susceptibility to Skin Cancer 4Johnson & Johnson Completes Initial Tender Offer for Cougar Biotechnology 2Johnson & Johnson Completes Initial Tender Offer for Cougar Biotechnology 3Johnson & Johnson Completes Initial Tender Offer for Cougar Biotechnology 4
    (Date:7/11/2014)... at the National Institute of Standards and Technology ... work more effectively, they often prove that necessity ... the case recently for M. Lorna De Leoz ... growing specialization of glycomics. Glycomics is the study ... that are attached to proteins and lipids and ...
    (Date:7/11/2014)... researchers, including scientists from the Max Planck Institute for ... major step in understanding photosynthesis, the process by which ... in its atmosphere and which is therefore crucial for ... The researchers report the first direct visualization of a ... in which a specific protein complex, photosystem II, splits ...
    (Date:7/11/2014)... transplantation of mesenchymal stem cells can stimulate neurogenesis in ... Alzheimer,s disease (AD) and improve tissue and function injury ... reported on the therapeutic effect of adipose-derived stem cells ... effect on oxidative injury and neurogenesis in the brain ... School of Life Sciences, Tsinghua University, China transplanted ADSCs ...
    Breaking Biology News(10 mins):A first direct glimpse of photosynthesis in action 2
    ... developing incontinence before middle age is determined by our ... to urinary incontinence, a study of twins at the ... Urinary incontinence is very common, especially among women, with ... life. Incontinence, overactive bladder and other lower urinary tract ...
    ... oxygen levels in water has applications for oil spills, ... professor at Michigan State University is poised to help ... isn,t new. The challenge, however, has been manufacturing one ... phosphates and biological wastes. Ruby Ghosh, associate professor of ...
    ... dead Phantom midge larvae ( Chaoborus spp.) may explain ... of fish, acidification and fish death in Swedish lakes. Researchers ... of using lake-bottom sediments to show when and how fish ... restorations in acidified regions. "It is actually just ...
    Cached Biology News:Genes an important factor in urinary incontinence 2Oxygen sensor invention could benefit fisheries to breweries 2Dead midges reveal living conditions of fish 2
    ... antibody raised against a partial ... Immunogen: SF3B2 (NP_006833, 592 ... recombinant protein with GST tag. ... NM_006842 ...
    ...
    Mouse monoclonal antibody raised against a partial recombinant FBXO11. NCBI Entrez Gene ID = FBXO11...
    Mouse monoclonal antibody raised against a partial recombinant ZNF155. NCBI Entrez Gene ID = ZNF155...
    Biology Products: